GL1X · GenesisL1 explorer

MolNFT v1 · #139642 · protein

Mycobacterium tuberculosis pantothenate kinase mutant F247A/F254A

5XLW: “Mycobacterium tuberculosis pantothenate kinase mutant F247A/F254A”. X-ray diffraction, 1 ligand (SO4), 7 pockets (best druggability 0.87). MolNFT v1 #139642 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
5XLW
Type
protein
Length
593 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Pantothenate kinase
EC
2.7.1.33
UniProt
P9WPA7
Ligands
SO4
Pockets
7 · best druggability 0.87

Structure

x-ray diffraction · 2 distinct chains · 47% helix, 19% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
BPantothenate kinase (EC 2.7.1.33)protein28747% helix, 18% strandP9WPA7
APantothenate kinase (EC 2.7.1.33)protein30648% helix, 19% strandP9WPA7

Ligands and binding sites

  • SO4 · Sulfate ion · ion · 4 copies · chains B, A
  • EDO · 1,2-ethanediol · additive · 20 copies · chains B, A
  • 1PE · Pentaethylene glycol · additive · chains B
  • PEG · Di(hydroxyethyl)ether · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

7 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
18180.870.9078EDO
26950.760.8159PEG, EDO, SO4
34260.650.7840EDO, 1PE, SO4
4780.510.8418EDO
5930.480.8118EDO

Interfaces

1 interface between chains.

  • B–A · 2161 Ų buried · 10 hydrogen bonds · protein-protein

Compared structures

  • 5XLW · Mycobacterium tuberculosis Pantothenate kinase mutant F247A/F254A · the same entry in another collection · chain B against B, TM-score 1.00
  • P9WPA7 · AlphaFold monomer V2.0 prediction for pantothenate kinase (P9WPA7) · a predicted model of the same protein · chain B against A, TM-score 0.93

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.